Nervgen Pharma Corp

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.78

+0.15 (+4.13%)

As of May 3, 10:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +230.4% upside

Low Target $8.17

Average Target $12.49

High Target $18.41

Current Price $3.78

Current
$3.78

Target
$12.49

$8.17 $12.49 avg $18.41

Scenario Analysis

Bear Case

$8.17

116.1%

Low target

Base Case

$12.49

+230.4%

Avg target

Bull Case

$18.41

+387.0%

High target

Risk/Reward

3.3x

Highly favorable

Price in Context

52-Week High

$8.49

-55.5% from high

52-Week Low

$2.57

+47.1% from low

Target vs 52W High

$12.49

+47.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%